causal
Argenx blocks antibody recycling to clear autoantibodies
Argenx's drugs target the biological pathway that recycles pathogenic autoantibodies; blocking that recycling lets the harmful antibodies leave the system, so there is nothing left to attack healthy cells.
causalpending
Speaker
JuliaEvidence Quote
“when we block that passage of recycling, then those antibodies just get out of the system”
Created: 11/17/2026, 3:39:21 AM
Your notes
Loading notes...